🔎 Trials Near Me

መነሻ › የጡንቻ ካንሰር › አሪዞና › Tucson

በTucson፣ AZ ለየጡንቻ ካንሰር የሚደረጉ ክሊኒካዊ ጥናቶች

ለየጡንቻ ካንሰር የሚደረጉ 20 ጥናቶች በTucson እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • The University of Arizona Cancer Center - North Campus ( Site 0055), Tucson
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT07060807

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • The University of Arizona Cancer Center - North Campus, Tucson
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT07007559

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • University of Arizona Cancer Center ( Site 0035), Tucson
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06966700

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

ተሳታዮችን በመፈለግ ላይ
  • University of Arizona Cancer Center, Tucson
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ሴፕቴ 2026 · NCT07214532

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • The University of Arizona Cancer Center - North Campus, Tucson
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07174336

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Arizona Clinical Research Center, Inc., Tucson
  • University of Arizona Cancer Center, Tucson
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ15 ሴፕቴ 2026 · NCT06492616

A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • University of Arizona Cancer Center, Tucson
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ8 ሴፕቴ 2026 · NCT07100106

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • University of Arizona, Tucson
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ሴፕቴ 2026 · NCT07287917

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • University of Arizona-Cancer Center, Tucson
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ሴፕቴ 2026 · NCT06072612

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Tucson Medical Center HealthCare, Tucson
እድሜ ከ18 እስከ 100 · ሁሉም ጾታዎች · የተሻሻለው በ6 ኦገስ 2026 · NCT05232916

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • USOR Arizona Oncology Associates, Tucson
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ኦገስ 2026 · NCT05579366

Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • University of Arizona Cancer Center - Prevention Research Clinic, Tucson
እድሜ ከ18 እስከ 55 · ሴቶች · የተሻሻለው በ27 ጁላይ 2026 · NCT06184750

Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • University of Arizona - Cancer Center, Tucson
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ጁን 2026 · NCT05696626

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • The University of Arizona Cancer Center, Tucson
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ፌብሩ 2026 · NCT06778863

First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • The University of Arizona Cancer Center, Tucson
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2025 · NCT05216432

High-Resolution Lower Dose Dedicated Breast Computed Tomography (CT)

ተሳታዮችን በመፈለግ ላይጤናማ ተሳታዮች ይቀበላሉ
  • University of Arizona, Tucson
እድሜ 40 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ24 ኦገስ 2025 · NCT03954431

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Arizona Oncology Associates, PC - HOPE, Tucson
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ኦገስ 2025 · NCT03053193

A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Arizona Oncology Associates, Tucson
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ19 ጁን 2025 · NCT06568692

Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss

ተሳታዮችን በመፈለግ ላይ
  • University of Arizona, Tucson
እድሜ 21 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ6 ኤፕሪ 2025 · NCT05484973

CtDNA Based MRD Testing for NAC Monitoring in TNBC

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Arizona Oncology, Tucson
እድሜ 18 እና ከዚያ በላይ · ሴቶች · የተሻሻለው በ7 ጃንዩ 2025 · NCT06230185

በሌሎች ከተሞች ለየጡንቻ ካንሰር የሚደረጉ ጥናቶች

በTucson ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።